Literature DB >> 26944371

Should the norepinephrine maximal dosage rate be greatly increased in late shock?

Christos Stefanou1, Lakis Palazis1, Areti Loizou1, Chrystalla Timiliotou1.   

Abstract

Any advanced shock eventually degenerates into vasoplegia, which responds weakly to vasopressors. The highest reported norepinephrine flow rate is 3 μg/kg/min. We present the case of a young explosion victim, who was transferred in late haemorrhagic shock. Apart from usual treatment (hydration, mass transfusion protocol), single-agent norepinephrine was used to maintain a mean arterial pressure (MAP) of >60-65 mm Hg. For several hours, norepinephrine flow was 7-10 times the aforementioned (highest reported) in order to achieve our goal; during which, further hydration or transfusion would not contribute to MAP elevation. Sequential Organ Failure Assessment (SOFA) severity score was 18 (expected mortality >99%). The patient survived without underperfusion-related damage. We conclude that norepinephrine dosages could potentially be greatly increased in late shock. We must resist giving up flow escalation based on its numerical value. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26944371      PMCID: PMC4785500          DOI: 10.1136/bcr-2015-213670

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Transfusion practices in massive haemorrhage in pre-intensive and intensive care.

Authors:  R Sinha; D Roxby
Journal:  Vox Sang       Date:  2011-04-25       Impact factor: 2.144

2.  Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: preliminary results of a randomized controlled trial.

Authors:  C Anne Morrison; Matthew M Carrick; Michael A Norman; Bradford G Scott; Francis J Welsh; Peter Tsai; Kathleen R Liscum; Matthew J Wall; Kenneth L Mattox
Journal:  J Trauma       Date:  2011-03

3.  Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure.

Authors:  O Abid; S Akça; P Haji-Michael; J L Vincent
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

4.  Characteristics of patients receiving vasopressors.

Authors:  Julie Benbenishty; Charles Weissman; Charles L Sprung; Mali Brodsky-Israeli; Yoram Weiss
Journal:  Heart Lung       Date:  2010-07-14       Impact factor: 2.210

5.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

6.  Catecholamine dosing and survival in adult intensive care unit patients.

Authors:  Marc Kastrup; Jan Braun; Magnus Kaffarnik; Vera von Dossow-Hanfstingl; Robert Ahlborn; Klaus-D Wernecke; Claudia Spies
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

7.  High-dose norepinephrine treatment: determinants of mortality and futility in critically ill patients.

Authors:  Donna Döpp-Zemel; A B Johan Groeneveld
Journal:  Am J Crit Care       Date:  2013-01       Impact factor: 2.228

Review 8.  Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update.

Authors:  Steven M Hollenberg; Tom S Ahrens; Djillali Annane; Mark E Astiz; Donald B Chalfin; Joseph F Dasta; Stephen O Heard; Claude Martin; Lena M Napolitano; Gregory M Susla; Richard Totaro; Jean-Louis Vincent; Sergio Zanotti-Cavazzoni
Journal:  Crit Care Med       Date:  2004-09       Impact factor: 7.598

9.  Resuscitative strategies in traumatic hemorrhagic shock.

Authors:  Adrien Bouglé; Anatole Harrois; Jacques Duranteau
Journal:  Ann Intensive Care       Date:  2013-01-12       Impact factor: 6.925

  9 in total
  1 in total

1.  Combining an antiviral with rituximab in EBV-related haemophagocytic lymphohistiocytosis led to rapid viral clearance; and a comprehensive review.

Authors:  Christos Stefanou; Christiana Tzortzi; Fotini Georgiou; Chrystalla Timiliotou
Journal:  BMJ Case Rep       Date:  2016-12-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.